Blueberry expansion adds optionality, but not enough to alter wait thesis

What happened

Zacks published a piece on September 21, 2026, arguing Mission's expanding Peruvian blueberry acreage could boost seasonal earnings, cash generation, and diversification as newer plantings mature. The deep value report already treats blueberries as a profitable but capital-intensive segment, with FY2025 operating income of $13.1 million, down from $18.6 million a year earlier. Mission continues to invest heavily in this area, with overall capex of $50-55 million annually largely directed toward international farming and blueberries, and the segment sells almost all production to a single distributor under an exclusive agreement. While the blueberry business offers a second crop to smooth seasonality and utilize Peru assets more fully, its contribution remains small relative to avocados and does not address the core thesis risks around Calavo integration, tariffs, and margin stability. Thus the article's 'hidden opportunity' framing is largely known and priced in, with execution yet to be proven.

Implication

Investors waiting for a better entry should not chase the stock based on the blueberry story alone. Watch for evidence that blueberry yields and profitability improve sustainably, which could add a few million dollars to EBITDA and support free cash flow, but the segment remains small and concentrated. Keep the primary focus on the Calavo acquisition closing and delivering at least a substantial portion of the targeted $25 million in synergies, along with Mission holding EBITDA margins near 8% despite tariff and trade uncertainty. If those core milestones fail or the stock remains above the $16 trim level, the blueberry optionality provides little margin of safety. Conversely, a pullback toward $11, combined with improving blueberry economics and merger progress, would make the risk-reward more attractive.

Thesis delta

The blueberry article does not materially alter the WAIT thesis. It reinforces that blueberry maturation could add seasonal earnings and cash flow, but the business remains small, capital intensive, and dependent on a single distributor. Investors should treat any blueberry-driven upside as a secondary factor; the primary catalysts remain Calavo closing and synergy realization, plus margin stability amid trade volatility.